NCT04127058View on ClinicalTrials.gov

Evaluating a New Iloperidone Titration Scheme in Bipolar I Disorder or Schizophrenia

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 7, 2019

Primary Completion Date

November 27, 2019

Study Completion Date

November 27, 2019

Conditions
Bipolar I DisorderSchizophrenia
Interventions
DRUG

Iloperidone

Oral Tablet

Trial Locations (1)

08009

Vanda Investigational Site, Marlton

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY